| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |